insights_auto
Why is ABVX down ၃.၁၁%?
Dive Deeperchevron_right
ABVX:EPA
Abivax SA
၈၀.၉၀ €
arrow_downward
-၃.၁၁%(-၂.၆၀) 1D
အောက် ၅, GMT+၂ ၁၇:၃၅:၂၁ · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ABVX...
Open
၈၃.၄၀ €
High
၈၃.၄၀ €
Low
၇၉.၈၅ €
Mkt. cap
၇၂၅.၁၄ ဋေ
Avg. vol.
၁.၅၆ သိန်း
Volume
၉.၉၁ သောင်း
52-wk high
၁၃၉.၀၀ €
52-wk low
၆၀.၄၅ €
EPS
-၅.၂၀ €
Shares outstanding
၈.၇၅ ကုဋေ
No. of employees
၉၈
Open
၈၃.၄၀ €
High
၈၃.၄၀ €
Low
၇၉.၈၅ €
Mkt. cap
၇၂၅.၁၄ ဋေ
Avg. vol.
၁.၅၆ သိန်း
Volume
၉.၉၁ သောင်း
52-wk high
၁၃၉.၀၀ €
52-wk low
၆၀.၄၅ €
EPS
-၅.၂၀ €
Shares outstanding
၈.၇၅ ကုဋေ
No. of employees
၉၈
News stories
From web sources and news partners
Simply Wall Street
·
ပြီးခဲ့သည့် ၁ နာရီ
Did New Science Board Just Shift BioCryst's (BCRX) Investment Narrative?
GlobeNewswire
·
ပြီးခဲ့သည့် ၄၀ မိနစ်
WISeQey Begins Trading on Nasdaq and SIX as WQEY
Los Angeles Times
·
ပြီးခဲ့သည့် ၁၂ မိနစ်
Stocks rise to the edge of an all-time high
Reuters
·
ပြီးခဲ့သည့် ၁၉ မိနစ်
COMMENTARY: TRADING DAY Nasdaq highs, Brazil surprise
Profile
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.
Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated.
The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France. Wikipedia
About Abivax SA
CEOMarc de Garidel | Hartmut J. Ehrlich
Employees၉၈
Founded၂၀၁၃ ဒီ ၄
Headquarters-
Sector-
Websiteabivax.com